Nadeem Qureshi
Biographic Data
| ID | 3603976 |
|---|---|
| NAME | Nadeem Qureshi |
| GIVEN NAMES | Nadeem |
| FAMILY NAME | Qureshi |
| SIGNATURE | QURESHI N |
| AFFILIATIONS | University of Nottingham |
| ORCID | 0000-0003-4909-0644 |
| VERIFIED | Yes |
| TOTAL WORKS | 13 |
| TOTAL CITATIONS | 9 |
| WORKS AS AUTHOR | 13 |
| WORKS AS EDITOR | 0 |
| FIRST PUBLICATION YEAR | 1997 |
| LATEST PUBLICATION YEAR | 2024 |
| H-INDEX | 1 |
Ethical implications of disparities in translation genomic medicine
Genomic medicine has the potential to contribute to the development of an array of novel technologies within the clinical armoury, making possible early detection and management of high-risk conditions such as cancer.Whilst significant impact has already been felt in the context of rare inherited single gene disorders, much of the advancement in patient care through genomic medicine more broadly is going to be made possible by research involving …
Long-term body mass index changes in overweight and obese adults and the risk of heart failure, cardiovascular disease and mortality
The majority of adults who are overweight or obese retain their degree of overweight or obesity over the long term. Individuals with stable severe obesity experience the worst heart failure, CVD and mortality outcomes. These findings highlight the high cardiovascular toll exacted by continuing failure to tackle obesity
How genomic information is accessed in clinical practice
Genomic technologies are having an increasing impact across medicine, including primary care. To enable their wider adoption and realize their potential, education of primary health-care practitioners will be required. To enable the development of such resources, understanding where GPs currently access genomic information is needed. One-hundred fifty-nine UK GPs completed the survey in response to an open invitation, between September 2017 and S…
Specialist recommendation for chemoprevention medications in patients at familial risk of breast cancer
In England, the National Institute for Health and Care Excellence guideline for familial breast cancer recommends chemoprevention for women at high and moderate familial risk of breast cancer. However, prescribing of chemoprevention has not improved since the introduction of the guideline in 2013. The study aims to identify the current practice, in England, of familial cancer specialists offering chemoprevention and recommending prescribing in pr…
Characteristics predicting recommendation for familial breast cancer referral in a cohort of women from primary care
Family history of breast and related cancers can indicate increased breast cancer (BC) risk. In national familial breast cancer (FBC) guidelines, the risk is stratified to guide referral decisions. We aimed to identify characteristics associated with the recommendation for referral in a large cohort of women undergoing FBC risk assessment in a recent primary care study. Demographic, family history, psychological and behavioural factors were colle…
Is family history still underutilised? Exploring the views and experiences of primary care doctors in Malaysia
Inclusion of diverse populations in genomic research and health services
Using web-based familial risk information for diabetes prevention
NTR1938
Beyond beliefs
Social science research on lifestyle-related diseases typically focuses on patients' understandings and beliefs and takes the clinical risk for granted. We interviewed 30 healthy UK patients at high risk of heart disease, recruited from a family history trial at 2 weeks and 6 months after a discussion with a clinician about their risk, lifestyle and medications. The participants took four different paths: (i) pharmaceutical (most common, risk red…
Familial influences on antenatal and newborn haemoglobinopathy screening
Objectives. To explore the origins and content of service users’ prior knowledge of universal antenatal and newborn screening for haemoglobin disorders; and to explore related familial communication and screening decisions, sources of support and the impact of carrier results on service users and their families. Design. A cross-sectional, qualitative study using semi-structured interviews with 37 purposively sampled service users. Results. Famili…
Using family history information to promote healthy lifestyles and prevent diseases; a discussion of the evidence
In addition to risk assessment, family history information can be used to personalize health messages, which are potentially more effective in promoting healthy lifestyles than standardized health messages. More research is needed on the evidence for the effectiveness of such a tool
Consanguinity and genetic morbidity in a British primary care setting
Pedigrees can be utilized as a General Practice screening tool to detect relevant genetic morbidity, not ascertained in General Practice records. The process is enhanced when a primary care worker, from the same culture as the volunteers, collects information using the patients' mother tongue
The Relevance of Cultural Understanding to Clinical Genetic Practice
Two decades ago, physicians in the USA made the unfortunate mistake of trying to provide mass sickle cell screening without counselling (Whitten 1973). Fortunately, with time, we came to appreciate the importance of appropriate counselling. Our understanding has now evolved further, and consideration of the cultural background of the individuals we are approaching is quite rightly considered an important issue. In the next few pages this issue wi…
Beyond beliefs
Social science research on lifestyle-related diseases typically focuses on patients' understandings and beliefs and takes the clinical risk for granted. We interviewed 30 healthy UK patients at high risk of heart disease, recruited from a family history trial at 2 weeks and 6 months after a discussion with a clinician about their risk, lifestyle and medications. The participants took four different paths: (i) pharmaceutical (most common, risk red…
Familial influences on antenatal and newborn haemoglobinopathy screening
Objectives. To explore the origins and content of service users’ prior knowledge of universal antenatal and newborn screening for haemoglobin disorders; and to explore related familial communication and screening decisions, sources of support and the impact of carrier results on service users and their families. Design. A cross-sectional, qualitative study using semi-structured interviews with 37 purposively sampled service users. Results. Famili…
The Relevance of Cultural Understanding to Clinical Genetic Practice
Two decades ago, physicians in the USA made the unfortunate mistake of trying to provide mass sickle cell screening without counselling (Whitten 1973). Fortunately, with time, we came to appreciate the importance of appropriate counselling. Our understanding has now evolved further, and consideration of the cultural background of the individuals we are approaching is quite rightly considered an important issue. In the next few pages this issue wi…
Consanguinity and genetic morbidity in a British primary care setting
Pedigrees can be utilized as a General Practice screening tool to detect relevant genetic morbidity, not ascertained in General Practice records. The process is enhanced when a primary care worker, from the same culture as the volunteers, collects information using the patients' mother tongue
Using family history information to promote healthy lifestyles and prevent diseases; a discussion of the evidence
In addition to risk assessment, family history information can be used to personalize health messages, which are potentially more effective in promoting healthy lifestyles than standardized health messages. More research is needed on the evidence for the effectiveness of such a tool
Familial influences on antenatal and newborn haemoglobinopathy screening
Objectives. To explore the origins and content of service users’ prior knowledge of universal antenatal and newborn screening for haemoglobin disorders; and to explore related familial communication and screening decisions, sources of support and the impact of carrier results on service users and their families. Design. A cross-sectional, qualitative study using semi-structured interviews with 37 purposively sampled service users. Results. Famili…
Beyond beliefs
Social science research on lifestyle-related diseases typically focuses on patients' understandings and beliefs and takes the clinical risk for granted. We interviewed 30 healthy UK patients at high risk of heart disease, recruited from a family history trial at 2 weeks and 6 months after a discussion with a clinician about their risk, lifestyle and medications. The participants took four different paths: (i) pharmaceutical (most common, risk red…
Using web-based familial risk information for diabetes prevention
NTR1938
Inclusion of diverse populations in genomic research and health services
How genomic information is accessed in clinical practice
Genomic technologies are having an increasing impact across medicine, including primary care. To enable their wider adoption and realize their potential, education of primary health-care practitioners will be required. To enable the development of such resources, understanding where GPs currently access genomic information is needed. One-hundred fifty-nine UK GPs completed the survey in response to an open invitation, between September 2017 and S…
Specialist recommendation for chemoprevention medications in patients at familial risk of breast cancer
In England, the National Institute for Health and Care Excellence guideline for familial breast cancer recommends chemoprevention for women at high and moderate familial risk of breast cancer. However, prescribing of chemoprevention has not improved since the introduction of the guideline in 2013. The study aims to identify the current practice, in England, of familial cancer specialists offering chemoprevention and recommending prescribing in pr…
Characteristics predicting recommendation for familial breast cancer referral in a cohort of women from primary care
Family history of breast and related cancers can indicate increased breast cancer (BC) risk. In national familial breast cancer (FBC) guidelines, the risk is stratified to guide referral decisions. We aimed to identify characteristics associated with the recommendation for referral in a large cohort of women undergoing FBC risk assessment in a recent primary care study. Demographic, family history, psychological and behavioural factors were colle…
Is family history still underutilised? Exploring the views and experiences of primary care doctors in Malaysia
Long-term body mass index changes in overweight and obese adults and the risk of heart failure, cardiovascular disease and mortality
The majority of adults who are overweight or obese retain their degree of overweight or obesity over the long term. Individuals with stable severe obesity experience the worst heart failure, CVD and mortality outcomes. These findings highlight the high cardiovascular toll exacted by continuing failure to tackle obesity
Ethical implications of disparities in translation genomic medicine
Genomic medicine has the potential to contribute to the development of an array of novel technologies within the clinical armoury, making possible early detection and management of high-risk conditions such as cancer.Whilst significant impact has already been felt in the context of rare inherited single gene disorders, much of the advancement in patient care through genomic medicine more broadly is going to be made possible by research involving …
Medicine (12 works) · BRCA gene mutations in cancer (7 works) · Family medicine (6 works) · Internal Medicine (5 works) · Biology (4 works) · Family history (4 works) · Nursing (4 works) · Psychology (4 works) · Public health (4 works) · Demography (3 works)